Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Wesche

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Structure (London, England : 1993)|December 13, 2006
Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeperZhulun Wang, Jinsong Liu, Athena Sudom, et al.
Neoplasia (New York, N.Y.)|April 9, 2008
The growth factor Midkine antagonizes VEGF signaling in vitro and in vivoEdward Htun van der Horst, Brendon T Frank, Lawrence Chinn, et al.
Analytical Biochemistry|June 27, 2007
An ultrasensitive high-throughput electrochemiluminescence immunoassay for the Cdc42-associated protein tyrosine kinase ACK1Shou-Hua Xiao, Ellyn Farrelly, John Anzola, et al.
Plos One|May 30, 2009
Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancerRoy Blum, Rashmi Gupta, Patricia E Burger, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2012
Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitorsXianYun Jiao, David J Kopecky, JinSong Liu, et al.
Plos One|October 14, 2010
Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial signaling pathwaysRoy Blum, Rashmi Gupta, Patricia E Burger, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2005
Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1Edward Htun van der Horst, Yan Y Degenhardt, Astrid Strelow, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2008
Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agentsHilary P Beck, Todd Kohn, Steven Rubenstein, et al.
Nature|March 30, 2002
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4Nobutaka Suzuki, Shinobu Suzuki, Gordon S Duncan, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitorsDavid J Kopecky, Xiaolin Hao, Yi Chen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Structure (London, England : 1993)|December 13, 2006
Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeperZhulun Wang, Jinsong Liu, Athena Sudom, et al.
Neoplasia (New York, N.Y.)|April 9, 2008
The growth factor Midkine antagonizes VEGF signaling in vitro and in vivoEdward Htun van der Horst, Brendon T Frank, Lawrence Chinn, et al.
Analytical Biochemistry|June 27, 2007
An ultrasensitive high-throughput electrochemiluminescence immunoassay for the Cdc42-associated protein tyrosine kinase ACK1Shou-Hua Xiao, Ellyn Farrelly, John Anzola, et al.
Plos One|May 30, 2009
Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancerRoy Blum, Rashmi Gupta, Patricia E Burger, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2012
Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitorsXianYun Jiao, David J Kopecky, JinSong Liu, et al.
Plos One|October 14, 2010
Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial signaling pathwaysRoy Blum, Rashmi Gupta, Patricia E Burger, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2005
Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1Edward Htun van der Horst, Yan Y Degenhardt, Astrid Strelow, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2008
Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agentsHilary P Beck, Todd Kohn, Steven Rubenstein, et al.
Nature|March 30, 2002
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4Nobutaka Suzuki, Shinobu Suzuki, Gordon S Duncan, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitorsDavid J Kopecky, Xiaolin Hao, Yi Chen, et al.
Pageof 3